Fate Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/08/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 13/11/2025 | Mar 2024Filed 13/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $2.1 | $1.3 | $1.7 | $1.9 | $1.6 | $3.1 | $6.8 | $1.9 | |
| −$30 | −$31 | −$32 | −$34 | −$38 | −$48 | −$38 | −$48 | |
| −$0.25 | −$0.26 | −$0.27 | −$0.29 | −$0.32 | −$0.40 | −$0.33 | −$0.47 | |
| 120 | 120 | 119 | 119 | 118 | 118 | 117 | 101 |
Trend